What were Anondita Medicare Ltd's latest quarterly results?
Anondita Medicare Ltd's latest quarterly results (Mar 2026) show
- PAT Growth YoY: +110.0% (insufficient_data)
- Revenue Growth YoY: +80.4%
- Operating Margin: 38.0% (volatile)
Anondita Medicare Ltd: Why Is It Outperforming Nifty 500?
ActiveRS +55.8%Average4w StreakRe-Entry
In , Anondita Medicare Ltd (Contraceptives/Protectives) is outperforming Nifty 500 with +55.8% relative strength. Fundamentals: Average. On a 4-week streak.
Anondita Medicare Ltd Key Facts
- PE Ratio
- 63.6x
- Market Cap
- ₹2,129 Cr
- PAT Growth YoY
- +110%
- Revenue Growth YoY
- +80%
- OPM
- 38.0%
- RS vs Nifty 500
- +55.8%
Avoid
What's Happening
🚫No earnings growth, no valuation discount — limited upside
📊Debt increased 38% YoY — leverage rising
👔Promoter stake down 0.6% this quarter
🌐FII stake increased 0.8% this quarter
Key Numbers
PAT Growth YoY
+110%
Insufficient Data
Revenue YoY
+80%
Insufficient Data
Operating Margin
38.0%
+300 bps YoY
PE Ratio
63.6
Current Price
₹1,177
Fundamental Score
57/100
Average
3Y PAT CAGR
+80%
Market Cap
2.1K Cr
Valuation
Slightly Undervalued12-Week Performance
Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.
12 weeks agoThis week
How Fast Is Anondita Medicare Ltd Growing?
Revenue, profit and margin growth rates
| Metric | YoY | 3Y CAGR | Trend |
|---|---|---|---|
| Revenue | +80% | — | Insufficient Data |
| PAT (Net Profit) | +110% | +80% | Insufficient Data |
| OPM | 38.0% | +300 bps | Volatile |
Other Top Contraceptives/Protectives Stocks Beating Nifty 500
Frequently Asked Questions: Anondita Medicare Ltd
Based on publicly available financial data. This is educational research, not investment advice.
Is Anondita Medicare Ltd's profit growing or declining?
Anondita Medicare Ltd's profit is growing with an insufficient_data trend.
- PAT Growth YoY: +110.0% (latest quarter)
- PAT Growth QoQ: +61.5% (sequential)
- 3-Year PAT CAGR: +80.0%
- Trend: Insufficient_data — consistent growth pattern
What is Anondita Medicare Ltd's revenue growth trend?
Anondita Medicare Ltd's revenue growth trend is insufficient_data.
- Revenue Growth YoY: +80.4%
- Revenue Growth QoQ: +53.7% (sequential)
How is Anondita Medicare Ltd's operating margin trending?
Anondita Medicare Ltd's operating margin is volatile.
- Current OPM: 38.0%
- OPM Change YoY: +3.0% basis points
- OPM Change QoQ: +3.0% basis points
What is Anondita Medicare Ltd's 3-year profit and revenue CAGR?
Anondita Medicare Ltd's long-term compounding rates
- 3-Year Profit CAGR: +80.0%
Is Anondita Medicare Ltd's growth accelerating or decelerating?
Anondita Medicare Ltd's earnings growth is insufficient_data with positive momentum on a sequential basis.
- YoY Acceleration: 0.0% bps
- Sequential Acceleration: +20.0% bps
Is Anondita Medicare Ltd overvalued or undervalued?
Anondita Medicare Ltd appears slightly undervalued based on our fair value analysis.
- Valuation Signal: Slightly Undervalued
- Current PE: 63.6x
- Price-to-Book: 16.5x
What is Anondita Medicare Ltd's current PE ratio?
Anondita Medicare Ltd's current PE ratio is 63.6x.
- Current PE: 63.6x
- Market Cap: 2.1K Cr
How does Anondita Medicare Ltd's valuation compare to its history?
Anondita Medicare Ltd's current PE is 63.6x.
- Current PE: 63.6x
- Valuation Assessment: Slightly Undervalued
What is Anondita Medicare Ltd's price-to-book ratio?
Anondita Medicare Ltd's price-to-book ratio is 16.5x.
- Price-to-Book (P/B): 16.5x
- Book Value per Share: ₹72
- Current Price: ₹1177
Is Anondita Medicare Ltd a fundamentally strong company?
Anondita Medicare Ltd is rated Average with a fundamental score of 57/100. This score is calculated from objective financial metrics
- Revenue Growth YoY: +80.4% (10% weight)
- PAT Growth YoY: +110.0% (10% weight)
- PAT Growth QoQ: +61.5% (10% weight)
- Margins stable (10% weight)
Is Anondita Medicare Ltd debt free?
Anondita Medicare Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹34 Cr
What is Anondita Medicare Ltd's return on equity (ROE) and ROCE?
Anondita Medicare Ltd's return ratios over recent years
- FY2025: ROCE 62.0%
- FY2026: ROCE 44.0%
Is Anondita Medicare Ltd's cash flow positive?
Anondita Medicare Ltd's operating cash flow is positive (FY2026).
- Cash from Operations (CFO): ₹11 Cr
- Free Cash Flow (FCF): ₹-52 Cr
- CFO/PAT Ratio: 32% (weak cash conversion)
What is Anondita Medicare Ltd's dividend yield?
Anondita Medicare Ltd currently does not pay a significant dividend (yield 0.00%).
- Dividend Yield: 0.00%
- Current Price: ₹1177
Who holds Anondita Medicare Ltd shares — promoters, FII, DII?
Anondita Medicare Ltd's shareholding pattern (Mar 2026)
- Promoters: 62.4%
- FII (Foreign): 3.4%
- DII (Domestic): 5.7%
- Public: 28.5%
Is promoter holding increasing or decreasing in Anondita Medicare Ltd?
Anondita Medicare Ltd's promoter holding has increased recently.
- Current Promoter Holding: 62.4% (Mar 2026)
- Previous Quarter: 61.8% (Sep 2025)
- Change: +0.61% (increasing — positive signal)
How long has Anondita Medicare Ltd been outperforming Nifty 500?
Anondita Medicare Ltd has been outperforming Nifty 500 for 4 consecutive weeks, indicating building momentum.
Is Anondita Medicare Ltd a new momentum entry or an established outperformer?
Anondita Medicare Ltd is a re-entry — it briefly dropped off the outperformance list but has now returned. Re-entries can signal renewed strength.
Is Anondita Medicare Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Anondita Medicare Ltd may be worth studying
- Earnings growing at +110.0% YoY
- Valuation: appears slightly undervalued
- Cash flow is positive — CFO ₹11 Cr
What is the investment thesis for Anondita Medicare Ltd?
Anondita Medicare Ltd investment thesis summary:
Research Signals (Bull Case)
- Revenue growing at +80.4% YoY
What is the future outlook for Anondita Medicare Ltd?
Anondita Medicare Ltd's forward outlook based on current data signals
- Earnings Trend: insufficient_data
- Revenue Trend: insufficient_data
- Margin Trend: volatile
- Valuation: Slightly Undervalued
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.